First-Line Atezolizumab OK'd for SCLC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-042
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Study: Atezolizumab Improves Survival in SCLC

Cancer Discovery
Oncology
2018English

Atezolizumab for the First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Frontiers in Oncology
Cancer ResearchOncology
2018English

Larotrectinib OK'd for Cancers With TRK Fusions

Cancer Discovery
Oncology
2018English

First-Line Drugs for Hypertension

Cochrane Database of Systematic Reviews
2018English

Experience of Using Atezolizumab in 1st Line Therapy of Metastatic Urothelial Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

First-Line Ibrutinib Confirmed for CLL

Cancer Discovery
Oncology
2018English

P109 Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients With Sensitive Relapsed SCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Competency Requirements for First-Line Managers

SA Journal of Human Resource Management
Human Resource ManagementDemographyOrganizational Behavior
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy